Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COPD (Part 2)”

22 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 22 results

Early research (Phase 1)Study completedNCT01661244
What this trial is testing

Investigate the Safety and Tolerability of a New Inhaled Formulation of RV568 in Healthy Volunteers

Who this might be right for
COPDHealthy Volunteers
Respivert Ltd 50
Testing effectiveness (Phase 2)Ended earlyNCT01972776
What this trial is testing

A Safety, Tolerability and Efficacy Study in Chronic Obstructive Pulmonary Disease (COPD) Patients With QBM076.

Who this might be right for
COPD
Novartis Pharmaceuticals 48
Testing effectiveness (Phase 2)Study completedNCT04540042
What this trial is testing

Study to Assess the Safety and Efficacy of SelK2 on Airway Responses Following Allergen Challenge in Subjects With Asthma (Part 1) and in Subjects With Chronic Obstructive Pulmonary Disease (Part 2)

Who this might be right for
AsthmaChronic Obstructive Pulmonary Disease
Tetherex Pharmaceuticals Corporation 61
Early research (Phase 1)Study completedNCT02059434
What this trial is testing

Two-part Pharmacokinetic and Pharmacodynamic Study of LAS190792 in Patients With Asthma and COPD

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)Asthma
AstraZeneca 55
Early research (Phase 1)Ended earlyNCT01068145
What this trial is testing

Two-Part Study to Evaluate the Dose Response of SCH 527123 on Sputum Neutrophilia Following Ozone Challenge in Healthy Subjects and Chronic Obstructive Pulmonary Disease (COPD) Patients (P05567 AM7)

Who this might be right for
Chronic Obstructive Pulmonary Disease
Merck Sharp & Dohme LLC 18
Testing effectiveness (Phase 2)Study completedNCT01728220
What this trial is testing

Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD

Who this might be right for
Pulmonary HypertensionChronic Obstructive Pulmonary Disease
Bellerophon Pulse Technologies 159
Testing effectiveness (Phase 2)Study completedNCT00478738
What this trial is testing

A 2 Part Study Examining Doses Of GSK961081 In Healthy Volunteers And Then In COPD Patients

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 82
Early research (Phase 1)Study completedNCT01921712
What this trial is testing

A Safety, Pharmacokinetic and Pharmacodynamic Study of PUR0200 in COPD Patients

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Pulmatrix Inc. 38
Early research (Phase 1)Study completedNCT06118684
What this trial is testing

Clinical Trial to Assess Effect of Verapamil on Systemic Exposure of EP395 and Effect of EP395 on Systemic Exposure of Midazolam and Digoxin

Who this might be right for
Chronic Obstructive Pulmonary Disease ExacerbationCOPD
EpiEndo Pharmaceuticals 37
Early research (Phase 1)Study completedNCT02267655
What this trial is testing

3 Part Study to Assess Inhaled Nitric Oxide on Functional Pulmonary Imaging in Subj. Pulmonary Hypertension Associated w/ COPD and IPF

Who this might be right for
Pulmonary HypertensionChronic Obstructive Pulmonary DiseaseIdiopathic Pulmonary Fibrosis
Bellerophon 8
Testing effectiveness (Phase 2)Study completedNCT00691405
What this trial is testing

A Dose Ranging Study of Arformoterol Given Once Daily Compared to Arformoterol Given Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
COPD
Sumitomo Pharma America, Inc. 215
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07822334
What this trial is testing

RO7830698 in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)Healthy Participants
Hoffmann-La Roche 104
Testing effectiveness (Phase 2)Study completedNCT00531050
What this trial is testing

Safety of Exercise and High-dose Salbutamol in Patients With Chronic Obstructive Pulmonary Disease (COPD) Receiving Therapeutic Doses of Indacaterol (QAB 149) and Salmeterol

Who this might be right for
Chronic Obstructive Pulmonary Disease
Novartis 27
Early research (Phase 1)Study completedNCT01083238
What this trial is testing

This Study Will Investigate How Food and Age Effect the Way the Body Handles the AZD5069 Drug Given as a Oral Dose

Who this might be right for
Chronic Obstructive Pulmonary Disease
AstraZeneca 24
Testing effectiveness (Phase 2)Study completedNCT02700919
What this trial is testing

Efficacy and Safety of BCT197 in Subjects With Acute Respiratory Exacerbations of Chronic Obstructive Pulmonary Disease

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Mereo BioPharma 282
Testing effectiveness (Phase 2)Study completedNCT05326412
What this trial is testing

Mechanistic Study of the Effect of Itepekimab on Airway Inflammation in Patients With COPD

Who this might be right for
Chronic Obstructive Pulmonary Disease
Sanofi 49
Testing effectiveness (Phase 2)Study completedNCT02130193
What this trial is testing

Investigation of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy of Oral Danirixin in Symptomatic COPD Subjects With Mild to Moderate Airflow Limitation at Risk for Exacerbations

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 102
Testing effectiveness (Phase 2)Study completedNCT06841640
What this trial is testing

Phase 1/Phase 2a Study of AERO-007 Inhalation Solution, a Nebulized LABA/LAMA Combination for Maintenance Treatment of COPD

Who this might be right for
COPD
AeroRx Therapeutics Inc. 24
Early research (Phase 1)Study completedNCT02573155
What this trial is testing

Two-part Safety, Tolerability, Pharmacodynamic and -Kinetic Study of Inhaled AZD8871 in Asthmatic and COPD Subjects

Who this might be right for
Asthma (Part 1)COPD (Part 2)
AstraZeneca 134
Not applicableStudy completedNCT02214056
What this trial is testing

Mobile Unit Screening of Pathologies Associated With Chronic Diseases - Feasibility

Who this might be right for
Chronic Obstructive Pulmonary DiseaseType II DiabetesAtherosclerosis
Centre Hospitalier Universitaire de Nīmes 27
Next Page